The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database
Open accessAbstract
OBJECTIVE: To examine changes in temporal trends in breast cancer mortality in women living in 30 European countries. DESIGN: Retrospective trend analysis. Data source WHO mortality database on causes of deaths Subjects reviewed Female deaths from breast cancer from 1989 to 2006 MAIN OUTCOME MEASURES: Changes in breast cancer mortality for all women and by age group (<50, 50-69, and >or=70 years) calculated from linear regressions of log transformed, age adjusted death rates. Joinpoint analysis was used to identify the year when trends in all age mortality began to change. RESULTS: From 1989 to 2006, there was a median reduction in breast cancer mortality of 19%, ranging from a 45% reduction in Iceland to a 17% increase in Romania. Breast cancer mortality decreased by >or=20% in 15 countries, and the reduction tended to be greater in countries with higher mortality in 1987-9. England and Wales, Northern Ireland, and Scotland had the second, third, and fourth largest decreases of 35%, 29%, and 30%, respectively. In France, Finland, and Sweden, mortality decreased by 11%, 12%, and 16%, respectively. In central European countries mortality did not decline or even increased during the period. Downward mortality trends usually started between 1988 and 1996, and the persistent reduction from 1999 to 2006 indicates that these trends may continue. The median changes in the age groups were -37% (range -76% to -14%) in women aged <50, -21% (-40% to 14%) in 50-69 year olds, and -2% (-42% to 80%) in >or=70 year olds. CONCLUSIONS: Changes in breast cancer mortality after 1988 varied widely between European countries, and the UK is among the countries with the largest reductions. Women aged <50 years showed the greatest reductions in mortality, also in countries where screening at that age is uncommon. The increasing mortality in some central European countries reflects avoidable mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
(2005) · Europe PMC (PubMed Central) · Cited by 1,975
ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics
McPherson, K. (2000) · BMJ · doi:10.1136/bmj.321.7261.624 · Cited by 1,570
Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer
Early Breast Cancer Trialists' Collaborative Group (1988) · New England Journal of Medicine · doi:10.1056/nejm198812293192601 · Cited by 933
Berrino, F., De Angelis, R., Sant, M., Rosso, S., Lasota, M. B., Coebergh, J. W., & Santaquilani, M. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70245-0 · Cited by 807
von Karsa, L., Anttila, A., Ronco, G., Ponti, A., Malila, N. K., Arbyn, M., Segnan, N., Castillo-Beltran, M., Boniol, M., Ferlay, J., et al. (2008) · Cited by 551
Self-citationVeronesi, U., Boyle, P., Goldhirsch, A., Orecchia, R., & Viale, G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66546-4 · Cited by 542
Jorgensen, K. J., & Gotzsche, P. C. (2009) · BMJ · doi:10.1136/bmj.b2587 · Cited by 502
Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women
Jemal, A., Ward, E., & Thun, M. J. (2007) · Breast Cancer Research · doi:10.1186/bcr1672 · Cited by 351
Cited by
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Aebi, S., Davidson, T., Gruber, G., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq159 · Cited by 2,842
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Cardoso, F., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rubio, I. T., Zackrisson, S., & Senkus, E. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz173 · Cited by 2,214
Screening for breast cancer with mammography
Gøtzsche, P. C., & Jørgensen, K. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub5 · Cited by 1,869
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Senkus, E., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rutgers, E., Zackrisson, S., & Cardoso, F. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv298 · Cited by 1,597
Lei, S., Zheng, R., Zhang, S., Wang, S., Chen, R., Sun, K., Zeng, H., Zhou, J., & Wei, W. (2021) · Cancer Communications · doi:10.1002/cac2.12207 · Cited by 1,113
Screening, T. I. U. P. O. B. C., Marmot, M. G., Altman, D. G., Cameron, D. A., Dewar, J. A., Thompson, S. G., & Wilcox, M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.177 · Cited by 1,069
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Loibl, S., André, F., Bachelot, T., Barrios, C. H., Bergh, J., Burstein, H. J., Cardoso, M. J., Carey, L. A., Dawood, S., Del Mastro, L., et al. (2024) · Annals of Oncology · doi:10.1016/j.annonc.2023.11.016 · Cited by 1,008
An overview of triple-negative breast cancer
Kumar, P., & Aggarwal, R. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3859-y · Cited by 771
Youlden, D. R., Cramb, S. M., Dunn, N. A. M., Muller, J. M., Pyke, C. M., & Baade, P. D. (2012) · Cancer Epidemiology · doi:10.1016/j.canep.2012.02.007 · Cited by 709
Triple-negative breast cancer: epidemiological considerations and recommendations
Boyle, P. (2012) · Annals of Oncology · doi:10.1093/annonc/mds187 · Cited by 593
Broeders, M., Moss, S., Nyström, L., Njor, S., Jonsson, H., Paap, E., Massat, N., Duffy, S., Lynge, E., & Paci, E. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012078 · Cited by 489
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Senkus, E., Kyriakides, S., Penault-Llorca, F., Poortmans, P., Thompson, A., Zackrisson, S., & Cardoso, F. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt284 · Cited by 479
Cancer mortality in Europe, 2005–2009, and an overview of trends since 1980
Bosetti, C., Bertuccio, P., Malvezzi, M., Levi, F., Chatenoud, L., Negri, E., & La Vecchia, C. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt301 · Cited by 464
Self-citationBreast cancer: an up‐to‐date review and future perspectives
Hong, R., & Xu, B. (2022) · Cancer Communications · doi:10.1002/cac2.12358 · Cited by 407
Diabetes and breast cancer risk: A meta-analysis
Boyle, P., Boniol, M., Koechlin, A., Robertson, C., Valentini, F., Coppens, K., Fairley, L.-L., Boniol, M., Zheng, T., Zhang, Y., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.414 · Cited by 358
Self-citationBenefits and harms of mammography screening
Løberg, M., Lousdal, M. L., Bretthauer, M., & Kalager, M. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0525-z · Cited by 368
Autier, P., Boniol, M., Gavin, A., & Vatten, L. J. (2011) · BMJ · doi:10.1136/bmj.d4411 · Cited by 300
Self-citationThe Global Breast Cancer Burden
Benson, J. R., & Jatoi, I. (2012) · Future Oncology · doi:10.2217/fon.12.61 · Cited by 274
Trends and predictions to 2020 in breast cancer mortality in Europe
Carioli, G., Malvezzi, M., Rodriguez, T., Bertuccio, P., Negri, E., & La Vecchia, C. (2017) · The Breast · doi:10.1016/j.breast.2017.06.003 · Cited by 264
Self-citationSmith, S. G., Sestak, I., Forster, A., Partridge, A., Side, L., Wolf, M. S., Horne, R., Wardle, J., & Cuzick, J. (2016) · Annals of Oncology · doi:10.1093/annonc/mdv590 · Cited by 263
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Aebi, S., Davidson, T., Gruber, G., & Cardoso, F. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr371 · Cited by 256
Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer
Gu, Y., Yang, R., Zhang, Y., Guo, M., Takehiro, K., Zhan, M., Yang, L., & Wang, H. (2025) · Molecular Biomedicine · doi:10.1186/s43556-024-00239-2 · Cited by 184
Metadata
- Authors
- Autier, P., Boniol, M., LaVecchia, C., Vatten, L., Gavin, A., Hery, C., & Heanue, M.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2010-08-11
- Volume
- 341
- Issue
- aug11 1
- Pages
- c3620-c3620
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2030593198
- Cited by
- 412
- References
- 38
- FWCI
- 22.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.